✉ Email this page to a colleague
« Back to Dashboard
Orvepitant is an investigational drug.
There have been 10 clinical trials for Orvepitant. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2009.
The most common disease conditions in clinical trials are Depressive Disorder, Disease, and Depressive Disorder, Major. The leading clinical trial sponsors are GlaxoSmithKline, Nerre Therapeutics Ltd., and Pharm-Olam International.
Recent Clinical Trials for Orvepitant
|Phase 2 Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With IPF||Pharm-Olam International||Phase 2|
|Phase 2 Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With IPF||Nerre Therapeutics Ltd.||Phase 2|
|Mass Balance Study of [14C]-Orvepitant Oral Solution in Healthy Male Subjects||Nerre Therapeutics Ltd.||Phase 1|